Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

The Obesity-Breast Cancer Conundrum: An Analysis of the Issues.

Matthews SB, Thompson HJ.

Int J Mol Sci. 2016 Jun 22;17(6). pii: E989. doi: 10.3390/ijms17060989. Review.

2.

Adipokines and Vascular Endothelial Growth Factor in Normal Human Breast Tissue in Vivo - Correlations and Attenuation by Dietary Flaxseed.

Morad V, Abrahamsson A, Kjölhede P, Dabrosin C.

J Mammary Gland Biol Neoplasia. 2016 Jun;21(1-2):69-76. doi: 10.1007/s10911-016-9352-9. Epub 2016 Apr 8.

3.

Breast cancer survival among young women: a review of the role of modifiable lifestyle factors.

Brenner DR, Brockton NT, Kotsopoulos J, Cotterchio M, Boucher BA, Courneya KS, Knight JA, Olivotto IA, Quan ML, Friedenreich CM.

Cancer Causes Control. 2016 Apr;27(4):459-72. doi: 10.1007/s10552-016-0726-5. Epub 2016 Mar 12. Review.

4.

Globular adiponectin enhances invasion in human breast cancer cells.

Falk Libby E, Liu J, Li YI, Lewis MJ, Demark-Wahnefried W, Hurst DR.

Oncol Lett. 2016 Jan;11(1):633-641. Epub 2015 Nov 24.

5.

Obesity and Breast Cancer: Molecular Interconnections and Potential Clinical Applications.

Simone V, D'Avenia M, Argentiero A, Felici C, Rizzo FM, De Pergola G, Silvestris F.

Oncologist. 2016 Apr;21(4):404-17. doi: 10.1634/theoncologist.2015-0351. Epub 2016 Feb 10.

PMID:
26865587
6.

Obesity and Cancer: An Angiogenic and Inflammatory Link.

Fukumura D, Incio J, Shankaraiah RC, Jain RK.

Microcirculation. 2016 Apr;23(3):191-206. doi: 10.1111/micc.12270. Review.

PMID:
26808917
7.

Serum irisin levels are lower in patients with breast cancer: association with disease diagnosis and tumor characteristics.

Provatopoulou X, Georgiou GP, Kalogera E, Kalles V, Matiatou MA, Papapanagiotou I, Sagkriotis A, Zografos GC, Gounaris A.

BMC Cancer. 2015 Nov 11;15:898. doi: 10.1186/s12885-015-1898-1.

8.

Leptin and Adiponectin Modulate the Self-renewal of Normal Human Breast Epithelial Stem Cells.

Esper RM, Dame M, McClintock S, Holt PR, Dannenberg AJ, Wicha MS, Brenner DE.

Cancer Prev Res (Phila). 2015 Dec;8(12):1174-83. doi: 10.1158/1940-6207.CAPR-14-0334. Epub 2015 Oct 20.

PMID:
26487401
9.

Circulating Adipokines and Inflammatory Markers and Postmenopausal Breast Cancer Risk.

Gunter MJ, Wang T, Cushman M, Xue X, Wassertheil-Smoller S, Strickler HD, Rohan TE, Manson JE, McTiernan A, Kaplan RC, Scherer PE, Chlebowski RT, Snetselaar L, Wang D, Ho GY.

J Natl Cancer Inst. 2015 Jul 16;107(9). pii: djv169. doi: 10.1093/jnci/djv169. Print 2015 Sep.

PMID:
26185195
10.

A Prospective Analysis of Plasma Adiponectin and Risk of Incident Cancer: The Dallas Heart Study.

Beg MS, Saleem S, Turer A, Ayers C, de Lemos JA, Khera A, Scherer PE, Lakoski SG.

J Natl Compr Canc Netw. 2015 Jul;13(7):873-8.

11.

Impact of Weight Loss on Plasma Leptin and Adiponectin in Overweight-to-Obese Post Menopausal Breast Cancer Survivors.

Thompson HJ, Sedlacek SM, Wolfe P, Paul D, Lakoski SG, Playdon MC, McGinley JN, Matthews SB.

Nutrients. 2015 Jun 26;7(7):5156-76. doi: 10.3390/nu7075156.

12.

The association of adiponectin gene promoter variations with non-small cell lung cancer in a Han Chinese population.

Li Y, Yao Y, Qian X, Shi L, Zhou J, Ma Q, Yao Y.

PLoS One. 2015 May 27;10(5):e0127751. doi: 10.1371/journal.pone.0127751. eCollection 2015.

13.
14.

Genetic variants of adiponectin and risk of colorectal cancer.

Song M, Gong J, Giovannucci EL, Berndt SI, Brenner H, Chang-Claude J, Curtis KR, Harrison TA, Hoffmeister M, Hsu L, Jiao S, Le Marchand L, Potter JD, Schoen RE, Seminara D, Slattery ML, White E, Wu K, Ogino S, Fuchs CS, Hunter DJ, Tworoger SS, Hu FB, Rimm E, Jensen M, Peters U, Chan AT.

Int J Cancer. 2015 Jul 1;137(1):154-64. doi: 10.1002/ijc.29360. Epub 2014 Dec 8.

15.

Association of endogenous sex hormones with adipokines and ghrelin in postmenopausal women.

Karim R, Stanczyk FZ, Brinton RD, Rettberg J, Hodis HN, Mack WJ.

J Clin Endocrinol Metab. 2015 Feb;100(2):508-15. doi: 10.1210/jc.2014-1839. Epub 2014 Nov 18.

16.

Changes in subcellular localization of visfatin in human colorectal HCT-116 carcinoma cell line after cytochalasin B treatment.

Bułdak RJ, Skonieczna M, Bułdak Ł, Matysiak N, Mielańczyk Ł, Wyrobiec G, Kukla M, Michalski M, Żwirska-Korczala K.

Eur J Histochem. 2014 Sep 12;58(3):2408. doi: 10.4081/ejh.2014.2408.

17.

Serum adiponectin is associated with worsened overall survival in a prospective cohort of hepatocellular carcinoma patients.

Siegel AB, Goyal A, Salomao M, Wang S, Lee V, Hsu C, Rodriguez R, Hershman DL, Brown RS Jr, Neugut AI, Emond J, Kato T, Samstein B, Faleck D, Karagozian R.

Oncology. 2015;88(1):57-68. doi: 10.1159/000367971. Epub 2014 Oct 3.

18.

Obesity and cancer: at the crossroads of cellular metabolism and proliferation.

O'Rourke RW.

Surg Obes Relat Dis. 2014 Nov-Dec;10(6):1208-19. doi: 10.1016/j.soard.2014.08.012. Epub 2014 Aug 27. Review. No abstract available.

19.

Adiponectin receptor signaling on dendritic cells blunts antitumor immunity.

Tan PH, Tyrrell HE, Gao L, Xu D, Quan J, Gill D, Rai L, Ding Y, Plant G, Chen Y, Xue JZ, Handa AI, Greenall MJ, Walsh K, Xue SA.

Cancer Res. 2014 Oct 15;74(20):5711-22. doi: 10.1158/0008-5472.CAN-13-1397. Epub 2014 Sep 26.

20.

Obesity as an important risk factor for certain types of cancer.

Davoodi SH, Malek-Shahabi T, Malekshahi-Moghadam A, Shahbazi R, Esmaeili S.

Iran J Cancer Prev. 2013 Fall;6(4):186-94. Review.

Items per page

Supplemental Content

Write to the Help Desk